Silence Therapeutics (SLN) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Silence Therapeutics

    NASDAQ: SLN · Real-Time Price · USD
    5.54
    0.54 (10.80%)
    At close: Sep 26, 2025, 3:59 PM
    5.54
    0.00%
    After-hours: Sep 26, 2025, 06:39 PM EDT

    Silence Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -7.17 -11.71 -10.02 -13.28
    PEG Ratio
    		 0.47 1.64 2.21 -1.33
    PS Ratio
    		 7.51 19.96 23.19 42.15
    PB Ratio
    		 2.42 29.71 18.39 61.38
    P/FCF Ratio
    		 -4.79 -12.86 -8.84 95.64
    P/OCF Ratio
    		 -4.8 -12.87 -8.93 76.90
    OCF/S Ratio
    		 -1.56 -1.55 -2.6 0.55
    Debt / Equity Ratio
    		 0.00 0.02 0.02 0.02
    Quick Ratio
    		 11.14 4.56 5.15 5.69
    Current Ratio
    		 11.14 4.56 4.41 5.69
    Asset Turnover
    		 0.21 0.27 0.16 0.13
    Interest Coverage
    		 n/a -1.46K -1.03K -5.73K
    Return on Equity
    		 -0.34 -2.54 -1.83 -4.62
    Return on Assets
    		 -0.22 -0.46 -0.38 -0.41
    Return on Invested Capital
    		 -0.35 -0.56 -0.48 -0.49
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.73 0.59 0.38 0.40
    Net Profit Margin
    		 -1.05 -1.71 -2.31 -3.17
    Pretax Profit Margin
    		 -1.03 -1.98 -2.71 -3.69
    Operating Profit Margin
    		 -1.46 -1.95 -2.78 -3.69
    FCF Margin
    		 -1.57 -1.55 -2.62 0.44
    EBITDA Margin
    		 -1.13 -1.96 -2.74 -3.66

    Add to Watchlist